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United in the Fight 
Indian S&T Establishments Come  
Together to Challenge COVID-19
IN recent times, rarely has an event galvanised the scientific community the world over as the coronavirus pandemic. When a pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO Country Office in China 
on 31 December 2019, there was no sign of the ominous events to follow – events 
that would lead to the rapid spread of one of the deadliest viruses in recent history 
through major parts of the world, eventually leading to 20% of humanity being 
placed under lockdown. Despite all efforts, the SARS-CoV-2 virus, which causes the 
COVID-19 disease, has afflicted more than 2.5 million people and caused more than 
1,79,725 deaths as the first quarter of the year rolled by. 
Even as the rapidly spreading virus was a gigantic challenge for governments, 
local administration and medical authorities round the world, the world scientific 
community scrambled to put together solutions that would put a check on the 
virus that spread almost like a wildfire. 
In India too, several scientific organisations and departments put together 
their resources and intensified their efforts at combating the pandemic through 
innovative solutions. Since it is not possible to document all the efforts, here’s a peek 
at just some of the efforts to mitigate the misery caused by the novel coronavirus so 
we can appreciate the hard work being put in by the Indian scientific community. 
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Hygiene & Sanitation – Frontline Defence against 
Coronavirus
Regular handwashing and sanitation are essential to keep away 
the novel coronavirus. Hand sanitisers contain ethyl alcohol, 
isopropyl alcohol or both to kill bacteria and viruses. Alcohols 
kill the virus by denaturing the protective outer proteins of 
microbes and dissolving their membranes. Similarly, soap 
molecules split open the outer fatty layer of the virus and thus 
kill it. 
However, as the pandemic spread, panic buying meant 
that hand sanitisers went out of stock. Several scientific 
organisations have therefore now come up with safe, low-cost 
and effective hand sanitisers. 
Scientists at the CSIR-Institute of Himalayan Bioresource 
Technology (CSIR-IHBT) based in Palampur, Himachal 
Pradesh, have developed an alcohol-based formulation 
of hand sanitiser with alcohol content as per the World 
Health Organization 
(WHO) guidelines. 
The hand sanitiser 
contains active tea 
ingredients, natural 
flavours and alcohol; 
chemicals like 
parabens, synthetic 
fragrance, triclosan 
and phthalates have 
not been used in 
the sanitiser. The 
technology has 
been transferred to 
a Palampur-based 
company M/s A.B. 
Scientific Solutions 
for commercial 
production.
The DST-Advanced Research Centre for Powder 
Metallurgy & New Materials (ARCI), Hyderabad, has also 
produced a hand sanitiser as per the WHO standards and 
distributed it among police personnel in Hyderabad, students, 
and staff of the institution. A team of scientists, students, and 
staff voluntarily came forward and produced about 40 litres 
of sanitizer.
Weinnovate Biosolutions, a Pune based startup supported 
jointly by the Department of Science and Technology (DST) 
and Department of Biotechnology (DBT), has developed a 
non-alcoholic aqueous-based colloidal silver solution uniquely 
made from its NanoAgCide technology for disinfecting hands 
and environmental surfaces.
CSIR-Indian Institute of Chemical Technology (CSIR-
IICT) prepared 250 L of hand sanitising gel and distributed 
to the Telangana Police. The process technology was 
transferred to a Rajasthan based MSME on 19 March 2020 
on non-exclusive basis and is also ready for transfer to any 
government organization, free of cost, provided they have 
sufficient raw materials.
Meanwhile, the CSIR-Indian Institute of Toxicology 
Research (CSIR-IITR), Lucknow also distributed hand 
sanitisers manufactured by it among people in essential 
services. The Institute handed over 10,000 sanitiser units 
to the district administration, 1800 litres for frontline care 
workers, and hand-rub sanitiser to the office of State Mission 
of Clean Ganga (SMCG), UP. CSIR-IITR also signed an 
agreement on 30 March 2020 with M/s ASPL Green Ventures 
(P) Ltd for sanitiser preparation.
The Defence Research & Development Organisation 
(DRDO) has also successfully developed in-house sanitisers 
and distributed approximately 4,000 litres of hand sanitizer 
to Indian Armed forces, Armed Forces Medical Corps, and 
Defence Security Corps; 1,500 litres to Ministry of Defence; 
300 litres to Parliament of India, and 500 litres to various 
security establishments and high offices.Hand sanitiser developed by CSIR-IHBT
Director, CSIR-IITR with the hand sanitiser developed by the Institute
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With the demand for soap rising as a protective measure 
against the highly contagious Coronavirus, the Palampur-
based CSIR institute, Institute of Himalayan Bioresource 
Technology (CSIR-IHBT) developed a herbal soap with natural 
saponins. The composition does not contain any mineral oil, 
SLES (Sodium Laureth sulphate) and SDS (Sodium dodecyl 
sulphate) and provides effective antifungal, antibacterial, 
cleansing and moisturising benefits. The technology has been 
transferred to two Himachal Pradesh based companies for 
commercial production and making available in major cities 
across the country.
In an interesting development in Bhubaneswar, the 
CSIR-Institute of Minerals and Materials Technology 
(CSIR-IMMT) has 
developed a hands-
free hand sanitising 
system which it 
plans to install at 
strategic locations 
in and around 
B h u b a n e s w a r 
city. The system 
is mechanically 
operated by foot 
for dispensing 
liquid soap for 
hand sanitisation 
and water flow for 
washing. It can be 
utilised either as a 
standalone compact 
unit with water 
source or can be 
attached to any 
existing washbasin. 
The operation 
doesn’t require 
electricity.
On similar lines, CSIR-CSIO has also developed a “Foot 
Controlled Water Tap” for delivering water from a plumbing 
system using foot. The use of foot for the operation avoids 
secondary transfer of germs/microbes of contagious nature 
CSIR-CIMAP prepared in its pilot facility and handed 
over 1000 bottles of its hand sanitiser (Hankool), 1000 bottles 
of floor disinfectant (Swabee) and 50 litres of floor cleaner 
(Cleangerm) to the Lucknow Nagar Nigam and District 
Magistrate for distribution.
CSIR-Institute of Minerals and Materials Technology 
(CSIR-IMMT), Bhubaneswar scientists are also working on 
an alcohol-based liquid hand-rub with plant extracts exhibiting 
aromatic and anti-infective activity. CSIR-IMMT aims to 
supply the sanitiser to the State Police Department and AIIMS 
Bhubaneswar.   
CSIR-IMMT scientists are also working on a process 
for the preparation of affordable soap bars with anti-infective 
property by using cold process of soap making. The method 
utilizes approved chemical ingredients along with metallic 
substances exhibiting antimicrobial activity. 
In March, CSIR-National Botanical Research Institute 
(CSIR-NBRI), Lucknow transferred herbal alcohol-based 
hand sanitiser technologies to two entrepreneurs for large-
scale production. Commercial production has already started. 
The Institute also developed a disinfectant and circulated the 
formula among the villagers for use in washing clothes and 
masks.
CSIR-IMMT’s hands-free sanitising system
Herbal alcohol-based hand sanitizer  
developed by CSIR-NBRI
Distribution of hand sanitisers at CSIR-CIMAP
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through common usage of faucet. Also, the tap does not 
use any external power. This tap can be installed in existing 
faucet systems for multi-level flow regulation. The technology 
has been transferred to M/s Jupiter Aqua Lines Limited, 
Mohali. 
Disinfection Machines
Surfaces that are not cleaned properly and disinfected regularly 
can become hotbeds for virus growth. Disinfecting surfaces, 
therefore, is essential. 
Scientists at the Sree Chitra Tirunal Institute for Medical 
Sciences and Technology (SCTIMST), Trivandrum, an 
Disinfected barrier-examination booth for examining COVID-19 patients 
developed by Sree Chitra Tirunal Institute for Medical Sciences and 
Technology (SCTIMST), Trivandrum
autonomous institute of the Department of Science and 
Technology (DST) have designed and developed a disinfected 
barrier-examination booth for examining COVID-19 patients. 
The innovative disinfected examination booth is closed like 
a telephone booth for examining the patient without direct 
contact with the doctor to prevent transmission of infection. 
It is equipped with a lamp, table fan, rack, and Ultraviolet 
(UV) light.
The CSIR-Central Scientific Instruments Organisation 
(CSIR-CSIO), Chandigarh has developed the Electrostatic 
Disinfection Spray Machine that can disinfect any surface, 
place or object. Based on the electrostatic principle, the 
machine produces uniform and fine charged spray droplets 
of disinfectant and sanitisation material in the range of 10-
20 µm, cover the directly exposed and obscured surfaces 
uniformly with increased efficiency. The machine uses 
very less disinfection material as compared to conventional 
methods. The technology for the machine has been transferred 
to the Bharat Heavy Electricals Limited (BHEL), which has 
already started its production in large numbers. CSIR-CSIO’s foot-operated water tap
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CSIR’s Durgapur-based laboratory, the Central 
Mechanical Engineering Research Institute (CSIR-CMERI) 
has developed a Disinfection Walkway that ensures maximum 
target coverage with minimum shadow area of an individual 
or an object. It can be deployed at multiple critical locations 
such as Isolation/Quarantine facilities, Mass Transit System 
CSIR-CMERI’s Disinfection Walkway
Entry points, Medical Centres and any other location with 
a considerable amount of footfall. The disinfectant used has 
no side effects such as itching, irritation, etc. A prototype of 
the Disinfection Walkway has been installed at CSIR-CMERI 
Medical Centre.
CSIR-CMERI has also come up with a Road Sanitiser 
Unit – a tractor-mounted Road Sanitising System with a span 
of 16 feet, which uses 15 to 35 bars of pressure to ensure 
effective delivery of the sanitiser. The system utilises a 
3000-litre tank with a pump of 22 LMP which can be used 
to sanitise a road stretch of up to 50 km. The first developed 
prototype is under trial run at CSIR-CMERI.
Tractor-mounted Road Sanitising System from CSIR-CMERI
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The Jawaharlal Nehru Centre for Advanced Scientific 
Research (JNCASR), Bengaluru, an autonomous institution 
under the DST, has developed a one-step curable anti-
microbial coating which when coated on different surfaces 
such as textile, plastic and so on could kill a range of virus 
types including COVID 19. The molecules developed have an 
ability to chemically cross-link with different surfaces upon 
UV irradiation. Upon the formation of the coating, it has 
been shown to permeabilize the membranes of pathogens (i.e. 
bacteria) leading to their inactivation.
 To take care of the safety of medical personnel in 
hospitals while treating coronavirus patients, CSIR-National 
Environmental Engineering Research Institute (CSIR-NEERI), 
Nagpur, has customised its Bench-scale Air Purification 
Scrubber (BAPS), meant for outdoor air pollution, to clean 
up indoor air pollution as well. The scrubber absorbs dust 
particles from the air, delivers it to the lower chamber of the 
system where it is treated with a mixture of disinfectant and 
soap water, which dissolves the fat membrane of the virus 
inactivating it. CSIR-NEERI has handed over the scrubber 
to the Mayo Hospital in Nagpur where nine corona positive 
patients are currently undergoing treatment. 
Similarly, a technology developed by an incubatee 
company of Scitech Park, Pune, under the NIDHI PRAYAS 
programme initiated by DST reduces the viral load of infected 
areas within a room significantly within an hour, a boon for 
hospitals. One hour of operation of the Ion generator machine 
reduces viral load within a room by 99.7% depending on 
room size.
Unravelling the Virus
Since understanding the enemy is important, two institutes – 
CSIR-Centre for Cellular and Molecular Biology (CCMB), 
Hyderabad, and CSIR-Institute of Genomics and Integrative 
Biology (IGIB), New Delhi – are working on sequencing the 
genome of the COVID-19 virus. With a better understanding 
of the evolution and dynamic nature of the virus, useful 
inferences could be drawn about the nature and working of 
the COVID-19 virus.
Testing for COVID-19
With the country reaching the stage in the course of the 
coronavirus pandemic where rapid testing has become 
essential, scientists of the CSIR-Institute of Genomics and 
Integrative Biology (IGIB), New Delhi, have come up with 
a low-cost, paper-strip coronavirus test which can detect the 
virus within an hour. The paper-strip test, similar to the test 
used to confirm pregnancy, utilises CRISPR-Cas9, a cutting-
edge gene-editing tool. Not only is the test cost-effective – it 
costs Rs 500 as compared to the PCR test being currently used 
and which costs Rs 4500 – the test does not need dedicated 
machinery or specialised skill. 
A rapid diagnostic kit is also being developed by a Pune-
based startup FastSense Diagnostics, funded by the Department 
of Science and Technology (DST). The company plans to 
roll out two products - a modified Polymerase chain reaction 
(PCR) based detection kit for confirmatory analysis in lesser 
time compared to existing detection methods (approximately 
50 samples can be tested in an hour) and a portable chip-based 
module for rapid screening of target population based on the 
on-chip sensing technology that would provide on the spot 
results in less than 15 min per sample. 
Meanwhile, CSIR-CEERI, Pilani along with CSIR-
IMTECH, IIT Ropar and TCS, Mumbai is also developing 
a portable and rapid COVID-19 detection device which will 
be based on antibody-antigen reaction. The Institute is also 
working with CSIR-NIIST, CSIR-IICB, IIT-Ropar and TCS, 
Mumbai develop a portable and instant COVID-19 detection 
device which will be based on Surface Enhanced Raman 
Spectroscopy (SERS) active chip and Artificial Intelligence-
based hand-held Raman spectrometer.
Laser
Monitoring of Label Free 
SERC
Healthy
COVID-19
The Rajiv Gandhi Centre for Biotechnology (RGCB), 
Thiruvananthapuram, is in the final stages of developing a 
rapid combined IgM, IgG lateral flow device, which is capable 
of detecting SARS COVID-19 infection as little as 4 days post-
infection of the virus. The kit is also capable of detecting IgG 
antibodies against the virus, which will reveal the status of the 
infected person’s ability to fight the virus. IgM detection can 
be deployed in check-points where asymptomatic patients can 
be identified and measures taken to isolate them preventing 
further spread. 
DBT’s Faridabad-based institute, the Translational 
Health Sciences and Technology Institute (THSTI), is also 
developing its own diagnostic kit for COVID-19. 
Developing Drugs & Vaccine
The novel coronavirus is a new virus for which neither drugs 
are available nor vaccines. To come up with immediate 
treatment options, the main focus is on working on the 
repurposing of existing drugs and synthesis of repurposed 
drugs. 
It has been identified that WHO approved drugs 
such as Paracetamol, Remdesivir, Hydroxychloroquine, 
Azithromycin, Flaviparavir, Lupinivir, etc. can be helpful 
for coronavirus treatment in India. Laboratories like 
CSIR-Indian Institute of Chemical Technology (CSIR-IICT) 
and CSIR-Central Drug Research Institute (CSIR-CDRI) will 
be carrying out repurposing of such drugs for COVID-19 
treatment as per WHO norms. Pharmaceutical company 
Cipla has already announced that it is fast-tracking repurposing 
of its wide variety of respiratory, asthma, anti-virals and 
HIV drugs to meet challenges arising from coronavirus in 
collaboration with scientists from the CSIR-IICT, Hyderabad. 
Schematic of instant screening device by CSIR-CEERI
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ICMR’s Efforts to Combat COVID-19 Pandemic
•	 India Bagged 5th Position Globally to Isolate the COVID-19 Virus Strain
ICMR, the apex Health Research Body of India, successfully isolated the CovID-19 virus strain and became 
the fifth nation after Japan, Thailand, United States of America and China who have isolated the strain. The 
isolation of the strain was the first step to accelerate the development of vaccines, therapeutics and rapid 
diagnostic kits in India.
•	 Scales up its Capacity to Flatten the Growth Curve of the Pandemic
ICMR has been working tirelessly to implement scientific interventions to battle COVID-19 and so expanded its 
capacity to diagnose and manage the outbreak. ICMR, which is also the testing agency for the infection, has 
extended its system of labs equipped to test COVID-19 from 51 to 65. The secondary test for reconfirmation of 
the infection which was earlier being conducted in ICMR-National Institute of Virology has additionally been 
extended to 31 labs. 
•	 Augmented Plan to Fast-track COVID-19 Testing Facilities
the council has released an augmented plan to fast-track CovID-19 testing laboratory scale-up including 
proactive search for potential laboratories that could be enabled for CovID-19 testing and inviting applications 
from all eligible private and Govt Medical Colleges to be a part of the battle against coronavirus pandemic. The 
official statement says, “As per directives of Hon’ble Union Minister of Home Affairs & Union Minister of Health 
& Family Welfare, under a core team of Director, All India Institute of Medical Sciences (AIIMS), Delhi; Director 
and Director General, ICMR, a total of 14 Centres of Excellence have been designated. These Centres have been 
delegated the responsibility of mentoring all the Govt & Private Medical Colleges in their catchment area and 
eventually create state-of-art molecular virology setups.”
•	 Data Portal Streamlining Data Collection from all Laboratories on Real-time Basis
ICMR has prepared a portal that provides complete information regarding CovID-19 including testing Strategy, 
kits, surveillance and prophylaxis treatment, preparation for a worst-case scenario and disease prevention and 
management.
•	 Sentinel Surveillance to Detect Community Transmission of the disease
ICMR has been the nodal agency for testing CovID-19 patients and closely monitoring the presence of 
community transmissions in India. The council has initiated from 15 February the sentinel surveillance for 
identifying community transmission of COVID-19. The surveillance sites have been scaled up from 16 sites till 
29 February 2020 to 51 sites by 15 March 2020. As per the official statement: “In view of the evolving nature 
of COVID19 transmission, the surveillance is being expanded to include more areas especially areas where 
COVID19 cases have been reported.”
In face of a shortage of drug intermediates or key starting 
materials, which will have to be imported from China at a 
huge cost, CSIR-National Chemical Laboratory (CSIR-NCL) 
has designed a roadmap for the synthesis and indigenous 
manufacture of drug intermediates and key starting materials 
for essential drugs. 
The Tata Consultancy Services (TCS) Ltd is also 
collaborating with the CSIR to design new chemical entities 
using Artificial Intelligence (AI) for treating COVID-19.
The Rajiv Gandhi Centre for Biotechnology is developing 
humanised monoclonal antibodies to treat COVID-19. 
Monoclonal antibodies are antibodies that recognise only 
specific proteins, called antigens, on the surface of specific 
bacteria or viruses. To deploy them as treatment, scientists 
take monoclonal antibodies produced by mice and change 
their protein sequences to resemble those of humans. 
These humanised monoclonal antibodies have a lower chance 
of being rejected by the patient’s body and can also be 
mass-produced in mouse cell lines. 
DBT’s National Institute of Immunology (NII) is also 
developing antibody-based therapy for COVID-19. It will 
procure coronavirus and blood samples from recovered 
patients, which will help in analysing the antibody 
quality in the blood with an aim to develop an antibody-based 
therapy. 
The Department of Science and Technology is to fund 
a Pune based company “Seagull Biosolutions Pvt. Ltd” first 
in India to develop Active Virosome (AV) Vaccine and 
Immunodiagnostic kits for COVID-19 emergency. The firm 
will use its existing Active Virosome Technology (AVT) 
which can develop novel Active Virosome agents to induce 
antibodies for both vaccine and kit. The company planned to 
develop two types of AV agents, one expressing S protein of 
COVID-19 (AV-S) and other expressing structural proteins 
of COVID-19 (AV-SPs). The firm, enrolled with the Union 
Ministry of Science & Technology under its Seed Support 
System scheme with the Technology Development Board, will 
conduct tests on wild mice to check the efficacy of the two AV 
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•	 National Task Force for COVID-19
ICMR set up a national task force to research COVID-19. The national task force constitutes the research groups 
including Clinical Research Group, Research on diagnostics and biomarkers, epidemiology and surveillance, 
operations research, vaccines/Drug research and development, to identify the research priorities and initiate 
research studies.
 The Terms of Reference (ToR) are as follows:
a) ldentify research priorities
  - Review evidence
  - Align them in consonance with the current level of outbreak and response
b) ldentify protocol lead and create a protocol development team
  - Develop concept notes
  - Develop complete protocols
c) ldentify partners for implementation
•	 TB Testing Machine to Detect COVID-19
to expand the testing facility for CovID-19, ICMR also approved the use of tuberculosis testing machine 
for conducting COVID-19 tests. The council validated TruenattM beta Cov test on truelabtM workstation and 
recommended it as a screening test for COVID-19. The ICMR has issued the guidance on the use of Truenat TM 
beta CoV  stating that throat/nasal swabs will be collected in the Viral Transport Medium (VTM) with virus lysis 
buffer provided along with the kit.
•	 ICMR Database being Used in Aarogya Setu App
The Indian Govt brought out the COVID-19 tracker App namely Aarogya Setu which is an initiative to keep 
people informed and alert against the outbreak by developing a bridge to battle against the disease. Aarogya 
Setu App needs one’s mobile number, location data (via GPS and Bluetooth), and matches the travelling 
history with that of the COVID-19 positive patients, documented by ICMR database in the backend.
•	 Role in Establishing Diagnosis of COVID-19
ICMR’s National Institute of Virology (NIV), Pune, serves as the resource centre for the Virus Research & 
Diagnostic Laboratories (VRDL) network and is responsible for providing technical training for performing 
molecular and serological assays for virological diagnosis. In view of the COVID-19 outbreak in India, NIV 
served as the apex laboratory to optimise the conventional and real-time PCR assays targeting different 
genomic regions of COVID-19 and initiate testing of suspected cases. 
agents. The initiative may help in diagnostics by providing 
safe and powerful immunizations.
Leads from Natural Products
CSIR is working closely with the Department of Ayush 
for developing preventive and prophylactic symptom 
management and add-on interventions to modern medicine 
treatments. For instance, its Jammu-based laboratory, Indian 
Institute of Integrative Medicine (CSIR-IIIM), is working on 
the development of Cocculus hirsutus and Glycyrrhiza glabra 
as phytopharmaceutical leads for COVID-19 in collaboration 
with Sun Pharma.
Another CSIR institute, the Lucknow-based Central Drug 
Research Institute (CSIR-CDRI) has also isolated important 
andrographolides, neoandrographolides and graphisides from 
Andrographis paniculata (Kalmegh) for testing their efficacy 
against COVID Sars-2. In silico target-based screening, studies 
suggest that some of these can inhibit critical proteins like the 
CL-proteinase of the pathogen. Kalmegh is an important plant 
CSIR-CDRI has isolated several single compounds from Andrographis  
paniculata commonly called ‘Kalmegh’ for anti-viral studies
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reported in traditional medicine, both as an immune booster 
and also for antiviral activities.
CSIR-IIIM is also exploring Zinc Gluconate and Proline 
as nutraceuticals and Unilever has agreed to partner with it to 
develop Zn-Gluconate and amino acid complex.
Medical Devices & Protective Equipments
With increasing numbers of patients, the availability of 
ventilators in hospitals could emerge as a major challenge. 
A ventilator is a mechanical breathing device that blows 
air and oxygen into the lungs and is critical for people with 
lung failure – a potentially fatal complication in patients with 
severe COVID-19. Several institutes in the country have 
come forward to develop ventilators. Similarly, protective 
equipment for medical personnel is also important as they 
work in close proximity to COVID-19 patients.
Ventilators
The Sree Chitra Tirunal Institute of Medical Sciences and 
Technology (SCTIMST), Trivandrum, has tied up with 
Wipro 3D, Bengaluru, to jointly build upon a prototype of 
an emergency ventilator system based on Artificial Manual 
Breathing Unit (AMBU). AMBU bag or a Bag-valve-mask 
(BVM) is a hand-held device used to provide positive pressure 
ventilation to a patient who is either not breathing or who is 
breathing inadequately.
CSIR has also started collaborating with BHEL on a 
war footing to develop ventilators to ensure ventilators are 
not in short supply when the disease enters the critical stage. 
For the moment, three CSIR labs are working on different 
types of ventilators. While CSIR-NAL is working on the Bi-
Level Positive Airway Pressure (BiPAP) system, CSIR-CSIO 
is working on the Respiration assistance intervention device 
(RESPaid), which is a portable ventilator. 
CSIR-CMERI has developed the prototype for a 
Mechanical Ventilator, which might be deployed to help huge 
volumes of prospective patients if required. The prototype 
has been equipped with multiple life-saving control features 
such as Tidal Volume, Breaths per Minute and Inspiratory/
Expiratory ratios. 
IIT Roorkee has developed a low-cost portable ventilator 
Prana-Vayu, in collaboration with AIIMS, Rishikesh. The 
automated process controls the pressure and flow rates in the 
inhalation and exhalation lines. 
Body Suits
Body Suits are critical requirements for doctors, medical staff, 
sanitation workers, etc. so that they do not contract COVID-19 
during their work. DRDO has developed a bodysuit for medical 
& paramedical staff. It is washable and has passed ASTM 
International standards. M/s Frontier Protective Wear Pvt. 
Ltd Kolkata and M/s Medikit Pvt. Ltd, Mumbai are producing 
10,000 suits per day.
Face Masks
CSIR is working on the production of self-disinfecting or 
reusable protective gears. CSIR-CSIO has designed an easy 
to fabricate Face Shield. The design uses easily available 
materials for production in volumes with a minimum 
CSIR-CECRI has developed 3D printed face shields to help protect  
doctors and nurses treating Covid-19 patients
3D printed protective face shields for doctors and  
paramedics developed by CSIR-CSMCRI
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The above material has been compiled from various sources including 
media, institutional reports, and more prominently from Science & 
Technology Efforts in India on Covid19 published by Vigyan Prasar 
and is in no way an exhaustive account of the S&T efforts being 
undertaken in India to combat COVID-19.
investment in materials and machines. The 
design is ergonomic with universal head 
size adaptability, avoids fogging, is ultra-
lightweight and provides ample room for 
wearing eyeglasses. Although, the face 
shield has been designed as disposable after 
use, however, the same can be reused after 
sanitization.
CSIR-CECRI has also developed 3D 
printed face shields to help protect doctors and 
nurses treating Covid-19 patients. 
Scientists of CSIR-CSMCRI have also 
used 3D printing technology to make protective 
face shields for doctors and paramedics. 
In these cost-effective shields, the frame 
is made of polylactic acetate (PLA) and the 
front transparent portion is made of cellulose 
acetate (OHP sheets). These have been sent 
to Bhavnagar Medical College and have been 
greatly appreciated by the medical fraternity.
The Science and Engineering Research 
Board (SERB), a statutory body under DST, 
is supporting research by a team of scientists 
from IIT Kanpur for developing a protective 
coating for making medicated masks and 
medical wear (PPE). The researchers will be 
designing the virucidal coating using polymers 
that can resist attachment of bacteria and 
virus. Additional protection will be included 
in the polymer coating using molecules 
that can either destabilise and/or neutralise 
coronaviruses and other viruses like influenza. 
The combination of anti-microbial polymer 
coating and functionalized drugs is also expected to provide a 
synergistic antiviral effect.
The DRDO has also come up with five-layer N99 masks 
with two layers of nanomesh. The mask costs Rs 70 per piece.
CSIR-NCL has initiated collaboration with Bharat 
Electronics Ltd (BEL) for the assembly/manufacture of 
contact-less digital IR thermometer and Oxygen enrichment 
device, both innovations from CSIR-NCL scientists and 
CSIR-NCL Venture Center. Multiple units of prototypes 
will be manufactured at BEL, Pune. Based on innovative, 
indigenous hollow-fibre membrane technology, the Membrane 
Oxygenator Equipment enriches oxygen in the air up to 35% 
under pressure (4-7 bar, using oil-free compressor).
CSIR-CMERI has also come up with a two-layered filter 
mask to ensure considerable facial area coverage. The dual-
layered filters ensure maximum protection against external 
infection. The replaceable filters are Hydrophobic (water-
resistant) and ensure perpetual use of the filter-support, which 
can be sterilized utilizing commonly used procedures. 
Structural Contributions
CSIR-SERC is gearing up to contribute towards fast, 
lightweight and prefabricated structures for makeshift 
hospitals and quarantine facilities to help prevent the spread of 
Digital IR thermometer using readily available modules from Venture Center,  
CSIR-NCL, Pune
CSIR-NCL-Genrich Oxygen enrichment unit medical equipment to be manufactured in  
collaboration with Bharat Electronics Ltd., Pune
COVID-19. The structures would be built utilizing lightweight 
material by ensuring safety and stability such that structures 
can be constructed in a couple of days. 
For the construction, it is proposed to employ precast units 
to reduce labour and time. The approximate cost for setting 
up the proposed structure is INR 25000-28000/- per sq m 
and the erection time at the site will be less than seven days 
(time requirement for fabrication of truss elements at factory 
and the foundation at the site will be 10-14 days). Additional 
INR 3000-5000/- per sq m may be required for mobility, 
toilet and other functional and specific requirements. The 
air filtration system, AC system and doctors’ rooms, 
anti-viral painting, etc if required, will have to be added 
appropriately. 
A 500-bed hospital for COVID-19 patients is also 
being constructed within a month in Haridwar. The hospital 
made of prefabricated structure will be constructed under 
the guidance of CSIR-Central Building Research Institute 
(CSIR-CBRI), Roorkee and IIT Roorkee.
